A 2-year phase II study with 1-year of follow-up of risedronate (NE-58095) in postmenopausal osteoporosis (Q40909946)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
A 2-year phase II study with 1-year of follow-up of risedronate (NE-58095) in postmenopausal osteoporosis
scientific article

    Statements

    A 2-year phase II study with 1-year of follow-up of risedronate (NE-58095) in postmenopausal osteoporosis (English)
    0 references
    Clemmesen B
    Ravn P
    Zegels B
    Taquet AN
    Christiansen C
    Reginster JY
    1 January 1997
    488-495

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit